Log inStart free trialBook a demo
Log inStart free trial
Media Database
>
Jayson Maclean

Jayson Maclean

Author at cantechletter.com at Cantech Letter

Contact this person
Email address
j*****@*******.comGet email address
Influence score
29
Location
Canada
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to Prowly

    View latest data and reach out all from one place
    Sign up for free

    Recent Articles

    cantechletter.com

    Curaleaf has a 90 per cent upside, says Beacon

    Beacon Securities analyst Russell Stanley likes the new European acquisition by US cannabis company Curaleaf Holdings, saying in a Thursday report that it cements CURA’s position as a European leader in cannabis.
    over 2 years ago
    cantechletter.com

    10 Best Canadian Dividend Stocks for Your Portfolio

    Cantech Letter hand-picks ten of the best from a range of industries, all with high yields, high market capitalization and a history of raising their dividends.
    over 2 years ago
    cantechletter.com

    Innergex is a “Strong Buy,” says iA Capital

    iA Capital Markets analyst Naji Baydoun provided an update on Innergex Renewable Energy on Tuesday where he reiterated a Strong Buy on the stock.
    over 2 years ago
    cantechletter.com

    Hasbro stock is a Buy, says Roth

    In a quarterly preview on Friday, Roth Capital Partners analyst Eric Handler reiterated a “Buy” rating and $74.00 target price on Hasbro.
    over 2 years ago
    cantechletter.com

    WELL Health stock should hit $10, Eight Capital says

    The new acquisition by Canadian digital health company WELL Health Technologies is a sharp pickup, says Eight Capital analyst Christian Sgro.
    over 2 years ago
    cantechletter.com

    Loop Industries is practically a double, says Roth

    Roth Capital Partners analyst Gerry Sweeney is keeping a bullish stance on Canadian cleantech company Loop Industries in a Friday report.
    over 2 years ago
    cantechletter.com

    Kits Eyecare is heading even higher, says Beacon

    The stock has already had a tremendous 2023, but investors can expect even more upside from Kits Eyecare, according to Beacon Securities analyst Doug Cooper, who provided an update to clients on Monday.
    over 2 years ago
    cantechletter.com

    WELL Health is a Buy, says Haywood

    The deals keep coming from WELL Health Technologies, with the latest getting the thumbs up from Haywood Capital Markets analyst Gianluca Tucci on Thursday.
    over 2 years ago
    cantechletter.com

    D-Wave Quantum wins target raise from Roth

    Roth Capital Partners analyst Suji Desilva boosted his target price on D-Wave Quantum, saying D-Wave is about to ride a wave of market interest in quantum computing.
    over 2 years ago
    cantechletter.com

    Docebo is heading higher, says ATB

    Top and bottom line beats look good on Docebo, according to ATB Capital Markets analyst Martin Toner, who provided an update on Thursday.
    over 2 years ago
    cantechletter.com

    Kinaxis is headed to $230, says Eight Capital

    Eight Capital analyst Christian Sgro reaffirmed a Buy rating on Kinaxis in a Friday update, saying he has confidence the supply chain management software company will hit its 2023 guidance targets.
    over 2 years ago